7081 PHARMA | Malaysia
PHARMANIAGA BHD
RM 0.73 on: 2022-01-20
+2.1% Past 1-day return
-4.58% Past 5-day return
Price/Valuation Analysis
Current Price Status
-
Stock is Trading within Range
Stock is trading within the fundamental outlook of the company and the industry average performance. Market is currently pricing of annual earning growth better than the industry average.
-
Company is in Positive Earning
Fair Value
- PHARMA current price is 9.59% below OneDelta estimated fair value.
-
The fair value is estimated via OneDelta proprietary model that updated daily basis based on stock fundamental and specific industry relative marco outlook. It can be assessed as stock potential upside range or the stock true value price in case of downside.
Relative Price Performance
-
Underperformed
PHARMA past 5-day return lagged behind the Pharmaceuticals industry average return by 3.72% -
Below 30-Day Average
Current price RM0.73 is below 30-day average RM0.74 by 1.4%
| Return (%) | PHARMA | Pharmaceuticals |
|---|---|---|
| 1-Day | +2.1% | +0.59% |
| 5-Day | -4.58% | -0.86% |
| 30-Day | -3.95% | +3.32% |
Bank Analyst Price Targets
BUY
RM 1.04
HOLD
RM 0.74
Revenue & Earning Growth Analysis
-
Cyclical Revenue Growth
PHARMA recorded various revenue growth in different quarters with no clear growth direction.
-
Unstable Profit Growth
PHARMA has been experiencing substantial ups and downs on profit growth.
Past Quarter Reports
| Quarter Date | Revenue (RM) | (%) | EPS (RM) | (%) |
|---|---|---|---|---|
| 2020-12-31 | 634,583k | +2% | -0.0242 | 0% |
| 2020-09-30 | 624,804k | -3% | 0.0055 | -86% |
| 2020-06-30 | 645,763k | -21% | 0.0382 | -55% |
| 2020-03-31 | 819,921k | +15% | 0.0857 | 0% |
| 2019-12-31 | 715,683k | -0% | -0.6845 | 0% |
Volume Trend Analysis
-
Recent Volume is Decreasing
Decreasing trading volume tends to keep stock price range bound in near term.
-
PHARMA recent daily traded volume is -20% lower than past month average.
| Past 30-Day | Past 5-Day |
|---|---|
| 20k daily | 16k daily |
Financials
Price History Chart
Past 30-day Average Price: RM0.74
Stock Fundamental Factors
Fundamental factor characteristics help us understand and expect how the stock price will behave in short and long term.
Stock Thematic Baskets
Usually the more the stock is included in popular themes, the more opportunity for price-driven momentum and better liquidity.
Market News & Investor Opinions
290,480 vials of Sinovac vaccine bottled by Pharmaniaga to be used from today
Pharmaniaga rises as much as 20.4% on bonus issue
Pharmaniaga proposes four-for-one bonus issue
Healthy outlook for Duopharma Biotech
Duopharma rises on strong earnings
Duopharma says 1Q net profit rises 30% on higher sales, proposes bonus issue
Duopharma posts higher Q1 net profit, vaccine deal to boost FY21 earnings
Duopharma earnings soar, plans bonus issue
CGS-CIMB Research upgrades Duopharma to add, TP RM3.67
Duopharma's bullish momentum to continue
Stock Company Profile
PHARMANIAGA BHD
Pharmaniaga Bhd. is an investment holding company. It engages in the research & development, manufacturing of generic pharmaceutical products, sales & marketing as well as logistics and distribution of pharmaceutical products & medical equipment. The firm operates through the following segments: Logistics and Distribution, Manufacturing, and Indonesia. The Logistics and Distribution segment engages in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia. The Manufacturing segment manufactures pharmaceutical products in Malaysia. The Indonesia segment manufactures and distributes pharmaceutical and medical products in Indonesia. The company was founded on August 21, 1998 and is headquartered in Shah Alam, Malaysia.